Cargando…

Long-term treatment with active Aβ immunotherapy with CAD106 in mild Alzheimer’s disease

INTRODUCTION: CAD106 is designed to stimulate amyloid-β (Aβ)-specific antibody responses while avoiding T-cell autoimmune responses. The CAD106 first-in-human study demonstrated a favorable safety profile and promising antibody response. We investigated long-term safety, tolerability and antibody re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farlow, Martin R, Andreasen, Niels, Riviere, Marie-Emmanuelle, Vostiar, Igor, Vitaliti, Alessandra, Sovago, Judit, Caputo, Angelika, Winblad, Bengt, Graf, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410460/ https://www.ncbi.nlm.nih.gov/pubmed/25918556 http://dx.doi.org/10.1186/s13195-015-0108-3

Ejemplares similares

Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study
por: Vandenberghe, Rik, et al.
Publicado: (2016)

Active immunotherapy options for Alzheimer’s disease
por: Winblad, Bengt, et al.
Publicado: (2014)

Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment
por: Huang, Chaorui, et al.
Publicado: (2002)

Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease
por: Andreasen, Niels, et al.
Publicado: (2010)

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
por: Langbaum, Jessica B., et al.
Publicado: (2020)

The rat as an animal model of Alzheimer’s disease
por: Benedikz, Eirikur, et al.
Publicado: (2009)

Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer’s disease
por: Caputo, Angelika, et al.
Publicado: (2023)

Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism
por: Smailovic, Una, et al.
Publicado: (2020)

The need for thorough phase II studies in medicines development for Alzheimer’s disease
por: Gray, Julian A., et al.
Publicado: (2015)

TMEM106B expression is reduced in Alzheimer’s disease brains
por: Satoh, Jun-ichi, et al.
Publicado: (2014)

The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease
por: Lopez Lopez, Cristina, et al.
Publicado: (2019)

Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
por: Landen, Jaren W., et al.
Publicado: (2017)

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease
por: Kramberger, Milica Gregoric, et al.
Publicado: (2012)

Occludin is overexpressed in Alzheimer's disease and vascular dementia
por: Romanitan, Mihaela Oana, et al.
Publicado: (2007)

The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Accelerated Progression From Mild Cognitive Impairment to Dementia in People With Diabetes
por: Xu, Weili, et al.
Publicado: (2010)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
por: Sandebring, Anna, et al.
Publicado: (2013)

European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment
por: Frederiksen, Kristian Steen, et al.
Publicado: (2020)

Addendum to proposal P 106: consideration on the time scale for P106
por: CERN. Geneva. Intersecting Storage-Rings Committee
Publicado: (1980)

A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons
por: Yu, Yang, et al.
Publicado: (2021)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Clinical Approach to Diagnosis of Pre-Dementia Alzheimer's Disease (CAD-PAD)
por: Alom, J., et al.
Publicado: (2012)

AutoCAD and AutoCAD LT essentials
por: Onstott, Scott
Publicado: (2017)

FreeSWITCH 106
por: Minessale, Anthony, et al.
Publicado: (2010)

S106. Submission Withdrawn
Publicado: (2018)

Acid Resistance of CAD/CAM Resin Composites
por: Schmohl, Leonie, et al.
Publicado: (2022)

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device
por: Eyjolfsdottir, Helga, et al.
Publicado: (2016)

Assessing cost-effectiveness of early intervention in Alzheimer’s disease: An open-source modeling framework
por: Green, Colin, et al.
Publicado: (2019)

Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice?
por: Robert, Philippe, et al.
Publicado: (2010)

Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
por: Aye, Sandar, et al.
Publicado: (2023)

EEG time signature in Alzheimer´s disease: Functional brain networks falling apart
por: Smailovic, Una, et al.
Publicado: (2019)

TGeoCad: an Interface between ROOT and CAD Systems
por: Luzzi, C, et al.
Publicado: (2014)

AutoCAD 2015 and AutoCAD LT 2015
por: Gladfelter, Donnie
Publicado: (2014)

AutoCAD 2014 and AutoCAD LT 2014
por: Gladfelter, Donnie
Publicado: (2013)

Autophagy Impairment in App Knock-in Alzheimer’s Model Mice
por: Jiang, Richeng, et al.
Publicado: (2022)

Development of GMP‐1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's disease
por: Pavlov, Pavel F., et al.
Publicado: (2018)

Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study
por: Leyhe, Thomas, et al.
Publicado: (2014)

AutoCAD /
por: Frey, David
Publicado: (2004)

CAD for LEP
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_oldl2r15fems7ab6enftrjjbj8